Olink Holding AB (publ) (OLK)
| Market Cap | 1.67B |
| Revenue (ttm) | 78.48M |
| Net Income (ttm) | -23.88M |
| Shares Out | 119.01M |
| EPS (ttm) | -0.28 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 210,644 |
| Open | 13.76 |
| Previous Close | 13.95 |
| Day's Range | 13.46 - 14.47 |
| 52-Week Range | 10.64 - 42.20 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 38.25 (+172.2%) |
| Earnings Date | Nov 10, 2021 |
About OLK
Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on. The company's products also comprise Olink NPX Manager, a purpose-built ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for OLK stock is "Buy." The 12-month stock price forecast is 38.25, which is an increase of 172.24% from the latest price.
News
Sequanta selects Olink® Explore 3072 to analyze new cohort study in China
UPPSALA, Sweden, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, will use Olink...
Why Olink Holding Stock Blasted Higher Today
The company posted some impressive anticipated growth figures in a new set of preliminary results.
Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021
UPPSALA, Sweden, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced preliminary unaudited revenue for the fourth quarter and year ended December 31, 2021, ...
Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart fa...
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein...
Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library ...
UPPSALA, Sweden, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the delivery of Olink ® Explore 3072 is now starting, providing customers with access to it...
Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize a...
UPPSALA, Sweden, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the winner of the young researchers' award, Novelties in Biomarkers , Melissa Amrein at the ...
Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink's multiplex protei...
UPPSALA, Sweden, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now starting the delivery of Olink ® Signature Q100, facilitating hands-on access fo...
Psomagen, Inc. Is Partnering with Olink Proteomics, Enabling Unprecedented Multi-Omics Clinical Studies
ROCKVILLE, Md.--(BUSINESS WIRE)-- #DNA--Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited facilities, h...
Olink reports third quarter 2021 financial results
UPPSALA, Sweden, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the third quarter of 2021.
Olink announces participation in November investor events
UPPSALA, Sweden, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that it will be participating in two investor events in November.
Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform
Strategic Partnership creates an end-to-end multi-omics platform for pharma, clinical research and biomarker discovery leveraging Fulgent's expansive test menu across genomics, transcriptomics, and now,...
Olink to report third quarter 2021 financial results on November 10, 2021
UPPSALA, Sweden, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the third quarter of 2...
Olink to present at two upcoming investor conferences
UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual...
CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services
UPPSALA, Sweden, Aug. 31, 2021 (GLOBE NEWSWIRE) -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech custome...
Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for ...
UPPSALA, Sweden, July 27, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB ( publ ) (“Olink”) (Nasdaq: OLK) today announced t h at CORAL, a new collaborative community of scientists , will use the Olink Proteo...
UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072
UPPSALA, Sweden, July 21, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the UK Biobank Pharma Proteomics Project (UKB-PPP Consortium) has decided to expand the ongo...
Why Olink Shares Are Getting Hammered Today
Olink Holding AB (publ) – ADR (NASDAQ:OLK) shares are trading lower by 11% at $31.94 after the company announced a public offering of 7 million ADSs by selling shareholders. Olink Holding AB has a propr...
Olink announces preliminary financial results for the second quarter 2021
UPPSALA, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB ( publ ) (“Olink”) (Nasdaq: OLK) today announce d preliminary unaudited revenue and net income (loss) for the second quarter ended Jun...
Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders
UPPSALA, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the launch of a public offering of 7,000,000 American Depositary Shar...
Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling
UPPSALA, Sweden, June 15, 2021 (GLOBE NEWSWIRE) -- Scallop-logo-470-pxOlink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the SCALLOP consortium (Systematic and Combined AnaLysis of Ol...
Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedic...
UPPSALA, Sweden, June 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink® Signature Q100, to allow more researchers access to Olink...
Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference
UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Confere...
Olink reports first quarter 2021 financial results and issues full year 2021 guidance
UPPSALA, Sweden, May 20, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the first quarter of 2021.
Olink to Report First Quarter 2021 Financial Results on May 20, 2021
UPPSALA, Sweden, April 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the first quarter of...
Olink Holding AB (publ) Announces Pricing of Initial Public Offering
Uppsala, Sweden, March 25, 2021 (GLOBE NEWSWIRE) -- Uppsala, Sweden – March 25, 2021 – Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its initial public...